MRK vs HUM
By Alex · Tickerpine
Merck & Co., Inc. vs Humana Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | HUM |
|---|---|---|
| Price | $128.66 | $383.84 |
| Market cap | $317.77B | $46.08B |
| P/E ratio | 36.2 | 41.0 |
| ROE | 18.94% | 6.28% |
| Profit margin | 13.59% | 0.82% |
| Revenue growth | 4.90% | 23.50% |
| Dividend yield | 2.64% | 0.92% |
| Beta | 0.22 | 0.77 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs HUM in plain English
- MRK is the bigger company — about 6.9× the market cap of HUM.
- MRK is cheaper on earnings (P/E 36.2 vs 41.0).
- MRK earns a higher return on equity (19% vs 6%).
- HUM is growing revenue faster (24% vs 5%).
- MRK has the higher dividend yield (2.64% vs 0.92%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
HUM return calculator
See what $1,000 in Humana Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.